Biological Activity |
Fidarestat (SNK 860) is an inhibitor of aldose reductase, with IC50s of 26 nM, 33 uM, and 1.8 uM for aldose reductase, AKR1B10 and V301L AKR1B10, respectively; Fidarestat (SNK 860) has the potential to treat diabetic disease. IC50 & Target: IC50: 26 nM (Aldose reductase), 33 uM (AKR1B10), 1.8 uM (V301L AKR1B10)[1] In Vitro: Fidarestat is an inhibitor of aldose reductase, with IC50s of 26 nM, 33 uM, and 1.8 uM for aldose reductase, AKR1B10 and V301L AKR1B10, respectively[1]. In Vivo: Fidarestat (SNK-860; 1 or 4 mg/kg. p.o., daily for 4 weeks) reduces the concentrations of sorbitol and fructose in diabetic rats[2]. |